The report provides in depth market analysis, information and insights into the insurance industry in Benin, including:
The Beninese insurance industry’s growth prospects by insurance segments and categories
The competitive landscape in the Beninese insurance industry
The current trends and drivers of the Beninese insurance industry
The challenges facing the Beninese insurance industry
The regulatory framework of the Beninese insurance industry
Summary
Benin has a small insurance industry, indeed the nation’s population is only 9 million strong. There were 12 insurers operating in the country in 2011 and as its economy is largely dependent on exports, these firms were indirectly affected by the global financial crisis. This led to a decline in the marine, aviation and transit insurance category. Insurance penetration as a percentage of GDP is low when compared to many developed countries. The Beninese insurance industry comprises both domestic and foreign insurance companies. The government’s liberalization policy abolished the regulatory barrier, which encouraged companies such as Allianz to enter the market.
Scope
This report provides a comprehensive analysis of the insurance industry in Benin:
It provides historical values for the Beninese insurance industry for the report’s 2008–2012 review period and forecast figures for the 2012–2017 forecast period
It offers a detailed analysis of the key segments and categories in the Beninese insurance industry, along with industry forecasts until 2017
It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, total investment income and retentions
It profiles the top insurance companies in Benin and outlines the key regulations affecting them
Reasons To Buy
Make strategic business decisions using in depth historic and forecast industry data related to the Beninese insurance industry and each segment within it
Understand the demand-side dynamics, key market trends and growth opportunities within the Beninese insurance industry
Assess the competitive dynamics in the Beninese insurance industry
Identify the growth opportunities and market dynamics within key segments
Gain insights into key regulations governing the Beninese insurance industry and its impact on companies and the industry''s future
Key Highlights
Benin has a small insurance industry, indeed the nation’s population is only 9 million strong.
There were 12 insurers operating in the country in 2011 and as its economy is largely dependent on exports, these firms were indirectly affected by the global financial crisis.
This led to a decline in the marine, aviation and transit insurance category.
Insurance penetration as a percentage of GDP is low when compared to many developed countries.
The Beninese insurance industry comprises both domestic and foreign insurance companies.
The government’s liberalization policy abolished the regulatory barrier, which encouraged companies such as Allianz to enter the market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=219409.
Contact sales@reportsandreports.com for further information.
Tuesday, 12 February 2013
Thursday, 7 February 2013
Market Overview of Hemophilia Industry - Therapeutic Class Report
Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors – Factor VIII (FVIII) and Factor IX (proteins in blood that control bleeding). Plasma-derived FVIII and FIX proteins were used in the 70’s for treating these disorders but transmission of contaminating viruses reduced its use. In 1999, recombinant FVIIIs and FIX, free of viral, animal, or human proteins became the standard of care (SoC). However, frequent injections used for prophylaxis resulted in development of antibodies (called inhibitors – acquired hemophilia or neutralizing abs) to FVIII or FIX. The presence of inhibitors complicated treatment of hemophilia A and B- ~30% in hemophilia A and up to 3 to 5% in hemophilia B pts. The high cost of treatment, frequent dosing, and infusion related adverse events are other concerns.
To address these limitations, companies are developing next generation clotting factors which are more potent – Short Acting or Long Acting Recombinant Factors. These potentially could result in fewer injections, reduce the inhibitor level, and improve compliance. Several of these pipeline products are now poised for approval and launch in the next two-three years. At present, Baxter, Bayer/ CSL, Pfizer, Novo Nordisk dominate the current ~$10b hemophilia market. In this report, we have analyzed the clinical efficacy, safety, and commercial prospects of the late-stage products in development and expect the long acting products that have best clinical and safety data to lead by offering patients better Cost per Quality Adjusted Life Year (QALY).
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218460.
Table of Contents
1. Executive Summary
2. Next Generation Recombinant FVIIIs and FIX
2.1 Short-acting or ‘Me-Too’ Recombinants
2.1.1 Hemophilia A: Late Stage Pipeline
a Turoctocog alfa
b BAY 81-8973
c Human-cl rhFVIII
2.1.2 Hemophilia B: Late Stage Pipeline
a BAX 326
b IB1001
2.2 Long-acting Recombinants
2.2.1 Modification used for extension of half-life of proteins
(PEGylation, Fc fusion, Genetic mutation, Novel single chain)
2.2.2 Hemophilia A: Late Stage Pipeline
a rFVIIIFc
b N8-GP
c BAY 94-9027
d CSL 627
e BAX 855
2.2.3 Hemophilia B: Late Stage Pipeline
a rFIXFc
b N9-GP
c CSL 654
2.3 Hemophilia with Inhibitors – Late Stage Pipeline
a BAY 86-6150
b CSL 689
c OBI-1
d BAX 817
e PF-05280602
f NecLip-rFVIIa
3. Novel Approaches for Hemophilia and Acquired Hemophilia
3.1 Gene Therapy
3.2 Tissue Factor Pathway Inhibitor (TFPI)
4. Biosimilar Development – A Safer Bet?
5. Market Forecast
5.1 Hemophilia A
5.2 Hemophilia B
5.3 Bypass Therapies – Hemophilia with Inhibitors
6. Current Marketed Therapies
6.1 FVIII Recombinants
a ADVATE
b Kogenate FS/ Helixate FS
c Xyntha
6.2 FIX Recombinants
a BeneFIX
6.3 Hemophilia with Inhibitors
6.3.1 Detection and Quantification
6.3.2
Treatment for Hemophilia with Inhibitors
(High-Dose Clotting Factor Concentrates, Bypassing Agents, Immune
Tolerance Induction – ITI Therapy)
6.3.3 Bypassing Agents
a NovoSeven / NovoSeven RT
b FEIBA
7. Cost of Treatment And Insurance
8. Hemophilia – About The Disease, Global Epidemiology, and
Acquired Hemophilia
8.1 Types of Hemophilia
8.2 Classification/ Severity of Disease
8.3 Acquired Hemophilia
8.4 Global Epidemiology
8.5 Mortality/Morbidity
8.6 Pathophysiology
8.7 Diagnosis
8.8 Treatment / Management
8.8.1 Prophylaxis
8.8.2 Episodic / On-Demand Therapy
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218460.
Contact sales@reportsandreports.com for further information.
To address these limitations, companies are developing next generation clotting factors which are more potent – Short Acting or Long Acting Recombinant Factors. These potentially could result in fewer injections, reduce the inhibitor level, and improve compliance. Several of these pipeline products are now poised for approval and launch in the next two-three years. At present, Baxter, Bayer/ CSL, Pfizer, Novo Nordisk dominate the current ~$10b hemophilia market. In this report, we have analyzed the clinical efficacy, safety, and commercial prospects of the late-stage products in development and expect the long acting products that have best clinical and safety data to lead by offering patients better Cost per Quality Adjusted Life Year (QALY).
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218460.
Table of Contents
1. Executive Summary
2. Next Generation Recombinant FVIIIs and FIX
2.1 Short-acting or ‘Me-Too’ Recombinants
2.1.1 Hemophilia A: Late Stage Pipeline
a Turoctocog alfa
b BAY 81-8973
c Human-cl rhFVIII
2.1.2 Hemophilia B: Late Stage Pipeline
a BAX 326
b IB1001
2.2 Long-acting Recombinants
2.2.1 Modification used for extension of half-life of proteins
(PEGylation, Fc fusion, Genetic mutation, Novel single chain)
2.2.2 Hemophilia A: Late Stage Pipeline
a rFVIIIFc
b N8-GP
c BAY 94-9027
d CSL 627
e BAX 855
2.2.3 Hemophilia B: Late Stage Pipeline
a rFIXFc
b N9-GP
c CSL 654
2.3 Hemophilia with Inhibitors – Late Stage Pipeline
a BAY 86-6150
b CSL 689
c OBI-1
d BAX 817
e PF-05280602
f NecLip-rFVIIa
3. Novel Approaches for Hemophilia and Acquired Hemophilia
3.1 Gene Therapy
3.2 Tissue Factor Pathway Inhibitor (TFPI)
4. Biosimilar Development – A Safer Bet?
5. Market Forecast
5.1 Hemophilia A
5.2 Hemophilia B
5.3 Bypass Therapies – Hemophilia with Inhibitors
6. Current Marketed Therapies
6.1 FVIII Recombinants
a ADVATE
b Kogenate FS/ Helixate FS
c Xyntha
6.2 FIX Recombinants
a BeneFIX
6.3 Hemophilia with Inhibitors
6.3.1 Detection and Quantification
6.3.2
Treatment for Hemophilia with Inhibitors
(High-Dose Clotting Factor Concentrates, Bypassing Agents, Immune
Tolerance Induction – ITI Therapy)
6.3.3 Bypassing Agents
a NovoSeven / NovoSeven RT
b FEIBA
7. Cost of Treatment And Insurance
8. Hemophilia – About The Disease, Global Epidemiology, and
Acquired Hemophilia
8.1 Types of Hemophilia
8.2 Classification/ Severity of Disease
8.3 Acquired Hemophilia
8.4 Global Epidemiology
8.5 Mortality/Morbidity
8.6 Pathophysiology
8.7 Diagnosis
8.8 Treatment / Management
8.8.1 Prophylaxis
8.8.2 Episodic / On-Demand Therapy
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218460.
Contact sales@reportsandreports.com for further information.
Tuesday, 5 February 2013
Market Outlook of France Orthopedic Devices Industry to 2018– Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation
ReportsnReports adds new market research reports on "France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others" to its store.
GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others” provides key market data on the France Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Orthopedic Devices market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within twelve market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the France Orthopedic Devices market.
- Key players covered include DePuy, Inc, Zimmer Holdings, Inc., Stryker Corporation, Synthes, Inc., Smith & Nephew Plc, Biomet, Inc.and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France Orthopedic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=190175.
Published: August 2012
No. of Pages: 325
Price: Single User: US $ 2500 Corporate User: US $ 7500
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=190175.
1 Table of Contents
2 Introduction 22
3 Orthopedic Devices In France 23
4 Arthroscopy In France 36
5 Cranio Maxillofacial Fixation (CMF) In France 60
6 Hip Reconstruction In France 83
7 Knee Reconstruction In France 104
8 Orthobiologics In France 127
9 Orthopedic Bone Cement and Casting Materials In France 150
10 Orthopedic Braces and Supports In France 171
11 Orthopedic Prosthetics In France 186
12 Orthopedic Tools In France 195
13 Other Joint Reconstruction In France 208
14 Spinal Surgery In France 232
15 Trauma Fixation In France 261
16 Overview of Key Companies in France Orthopedic Devices Market 282
17 Orthopedic Devices Market Pipeline Products 298
18 Financial Deals Landscape 307
19 Recent Developments 308
20 Appendix 309
1.1 List of Tables
Contact sales@reportsandreports.com for further information.
GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2018 – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others” provides key market data on the France Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Orthopedic Devices market categories – Trauma Fixation, Knee Reconstruction, Hip Reconstruction, Spinal Surgery, Arthroscopy, Orthopedic Braces and Supports, Orthobiologics, Cranio Maxillofacial Fixation (CMF), Other Joint Reconstruction, Orthopedic Bone Cement and Casting Materials, Orthopedic Tools and Orthopedic Prosthetics.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within twelve market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the France Orthopedic Devices market.
- Key players covered include DePuy, Inc, Zimmer Holdings, Inc., Stryker Corporation, Synthes, Inc., Smith & Nephew Plc, Biomet, Inc.and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France Orthopedic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=190175.
Published: August 2012
No. of Pages: 325
Price: Single User: US $ 2500 Corporate User: US $ 7500
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=190175.
1 Table of Contents
2 Introduction 22
3 Orthopedic Devices In France 23
4 Arthroscopy In France 36
5 Cranio Maxillofacial Fixation (CMF) In France 60
6 Hip Reconstruction In France 83
7 Knee Reconstruction In France 104
8 Orthobiologics In France 127
9 Orthopedic Bone Cement and Casting Materials In France 150
10 Orthopedic Braces and Supports In France 171
11 Orthopedic Prosthetics In France 186
12 Orthopedic Tools In France 195
13 Other Joint Reconstruction In France 208
14 Spinal Surgery In France 232
15 Trauma Fixation In France 261
16 Overview of Key Companies in France Orthopedic Devices Market 282
17 Orthopedic Devices Market Pipeline Products 298
18 Financial Deals Landscape 307
19 Recent Developments 308
20 Appendix 309
1.1 List of Tables
Contact sales@reportsandreports.com for further information.
Saturday, 2 February 2013
ReportsnReports: South Africa Ophthalmic devices Market Outlook to 2018
GlobalData’s new report, “South Africa Ophthalmic devices Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others” provides key market data on the South Africa Ophthalmic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope of the report:
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the South Africa Ophthalmic Devicesmarket.
- Key players covered include Essilor International, Johnson & Johnson Vision Care, Inc., CooperVision, Inc., Hoya Corporation, CIBA Vision Corporation, Alcon, Inc. and others.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218185.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218185.
1 Table of Contents
2 Introduction 15
3 Ophthalmic Devices In South Africa 16
4 Cataract Surgery Devices In South Africa 29
5 Glaucoma Surgery Devices In South Africa 47
6 Intraocular Lens (IOL) In South Africa 55
7 Ophthalmic Diagnostic Equipment In South Africa 73
8 Refractive Surgery Devices In South Africa 103
9 Vision Care In South Africa 122
10 Vitreo Retinal Surgery Devices In South Africa 154
11 Overview of Key Companies in South Africa Ophthalmic Devices Market 175
12 Ophthalmic Devices Market Pipeline Products 188
13 Financial Deals Landscape 191
14 Appendix 195
1.1 List of Tables
1.2 List of Figures
Contact sales@reportsandreports.com for further information.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope of the report:
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the South Africa Ophthalmic Devicesmarket.
- Key players covered include Essilor International, Johnson & Johnson Vision Care, Inc., CooperVision, Inc., Hoya Corporation, CIBA Vision Corporation, Alcon, Inc. and others.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218185.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218185.
2 Introduction 15
3 Ophthalmic Devices In South Africa 16
4 Cataract Surgery Devices In South Africa 29
5 Glaucoma Surgery Devices In South Africa 47
6 Intraocular Lens (IOL) In South Africa 55
7 Ophthalmic Diagnostic Equipment In South Africa 73
8 Refractive Surgery Devices In South Africa 103
9 Vision Care In South Africa 122
10 Vitreo Retinal Surgery Devices In South Africa 154
11 Overview of Key Companies in South Africa Ophthalmic Devices Market 175
12 Ophthalmic Devices Market Pipeline Products 188
13 Financial Deals Landscape 191
14 Appendix 195
1.1 List of Tables
1.2 List of Figures
Contact sales@reportsandreports.com for further information.
Wednesday, 9 May 2012
Market Research | Analysis of the Global Mobile Backhaul and Wireless Core Market
ReportsnReports add new market research report"Analysis of the Global Mobile Backhaul and Wireless Core Market" to its store. An analysis of the mobile backhaul test equipment market is provided in this research service. This market covers two segments including pre-deployment and post-deployment mobile backhaul test equipment. Frost & Sullivan predicts growth for the global mobile backhaul test equipment market from 2012 through 2018.This study analyzes the market trends across the major global regions, including North America, Europe, Asia Pacific, and Emerging regions. Also featured within the study are market drivers, restraints, revenue, technology trends, market shares of leading companies, and the future deployment plans of 4G standards globally.
Buy your copy of this report @ http://www.reportsnreports.com/reports/158466-analysis-of-the-global-mobile-backhaul-and-wireless-core-market.html
Reports Details:
Published: April 2012
No. of Pages: 122
Price : US $ 6000
Table of Contents
Executive Summary
Market Overview
Total Mobile Backhaul Test Equipment Market
External Challenges: Drivers and Restraints
Forecasts and Trends
Market Share and Competitive Analysis
Mega Trends and Industry Convergence Implications
Pre-deployment Mobile Backhaul Test Equipment Segment Breakdown
Pre-deployment Mobile Backhaul Test Equipment—North America Breakdown
Pre-deployment Mobile Backhaul Test Equipment—Europe Breakdown
Pre-deployment Mobile Backhaul Test Equipment—APAC Breakdown
Pre-deployment Mobile Backhaul Test Equipment—Emerging Market Breakdown
Post-deployment Mobile Backhaul Test Equipment Segment Breakdown
Post-deployment Mobile Backhaul Test Equipment—North America Regional Breakdown
Post-deployment Mobile Backhaul Test Equipment—Europe Regional Breakdown
Post-deployment Mobile Backhaul Test Equipment—APAC
Post-deployment Mobile Backhaul Test Equipment—Emerging Market Breakdown
The Last Word
Appendix
Saturday, 28 April 2012
Global and China Marine Diesel Engine Industry Report, 2011 | Manufacturing & Construction Industry
ReportsnReports add new market research report"Global and China Marine Diesel Engine Industry Report, 2011" to its store. The marine diesel engine is crowned as the
“heart” that provides power for the vessel, falling into low-speed,
middle-speed and high-speed marine diesel engines. Presently, the
world’s two prominent marine diesel engine brands are MAN and Wartsila,
of which the former is regarded as the low-speed marine diesel engineer
tycoon, while the latter is the middle-speed titan.
The new vessel orders worldwide witnessed steep drop in 2011, causing the bleak demand for marine diesel engine. The order book of MAN Diesel & Turbo saw a year-on-year increase of 6.2%, but the figure was far behind that of 18.6% in 2010; by contrast, the order value of Wartsila Ship Power decreased by 7.7% year-on-year.
In order to enhance competitive edge and consolidate the market dominance, international marine diesel engine giants in 2011 accelerated their expansion in the Chinese market. In May, the phase-Ⅱ project of MAN Diesel & Turbo started business in Changzhou; in June, Wartsila and Jiangsu Cuixing Ocean Engineering established a joint venture which was specialized in the production of W26, W32 four-stroke middle-speed engine; in November, Caterpillar teamed up with Anqing CSSC Marine Diesel Co., Ltd. to set up a joint venture which was also the world’s only joint venture of Caterpillar in middle-speed marine diesel engine sector.
Chinese marine diesel engine enterprises made remarkable progress in many aspects such as capacity, product structure and independent R&D through import.
Improvement in the Level of Production
In 2010, the low-speed marine diesel engine capacity of China hit 12 million horsepower, while the output realized 4.306 million horsepower, rising 39.4% over 2007.And the middle-speed marine diesel engine output registered 8.245 million horsepower, an increase of 73.1% over 2007.
In 2011, the production of marine diesel engine in China witnessed remarkable progress over 2010, with the output of Dalian Marine Diesel Co., Ltd., Yichang Marine Diesel Engine Co., Ltd., Zhenjiang CME Co., Ltd. reaching 101 units (1.63 million horsepower), 101 units (1.04 horsepower) and 713 units (including 14 units of low-speed engines). By contrast, both the output of Hefei RongAn Power Machinery Co., Ltd. and Jiangsu Antai Power Machinery Co., Ltd. doubled year-on-year to 40 units.
Gradual Perfection in Product Structure
In recent years, China’s marine diesel engine enterprises have intensified their efforts to adjust product structure, developed and realized mass-production of high-power, big-cylinder diameter or intelligent low-speed marine diesel engines, new-type middle-speed diesel engines, etc, making it possible for China to make gradual progress in the domestication R&D of patent marine diesel engines.
The IMO TierⅡ standard of marine diesel engine was formally effective since Jan.1, 2011. Coupled with the IMO TierⅢ standard that is to take effect in 2016, the relevant enterprises are forced to make continual effort to facilitate the structural adjustment of marine diesel engines, in a bid to accelerate the environment friendly-driven model.
Breakthrough in Independent R&D Capability
In April 2011, the first independently developed low-speed engine, 6S42MC/ZJ3#, by Zhenjiang CME Co. Ltd (ZJCME) was delivered; then in November, CSIC successfully developed middle-speed diesel engine, 6CS21/32, and formally launched it into the market
The new vessel orders worldwide witnessed steep drop in 2011, causing the bleak demand for marine diesel engine. The order book of MAN Diesel & Turbo saw a year-on-year increase of 6.2%, but the figure was far behind that of 18.6% in 2010; by contrast, the order value of Wartsila Ship Power decreased by 7.7% year-on-year.
In order to enhance competitive edge and consolidate the market dominance, international marine diesel engine giants in 2011 accelerated their expansion in the Chinese market. In May, the phase-Ⅱ project of MAN Diesel & Turbo started business in Changzhou; in June, Wartsila and Jiangsu Cuixing Ocean Engineering established a joint venture which was specialized in the production of W26, W32 four-stroke middle-speed engine; in November, Caterpillar teamed up with Anqing CSSC Marine Diesel Co., Ltd. to set up a joint venture which was also the world’s only joint venture of Caterpillar in middle-speed marine diesel engine sector.
China
Marine Diesel Engine Industry
Published: April 2012
No. of Pages: 69
In
China, the production of all low-speed diesel engines should be
accredited by foreign tycoons such as MAN and Wartsila (occupying over
95%). In particular, one third of middle-speed diesel engines are
licensed by MAN and Wartsila, being mainly applied as generating units
of ocean vessels. And the rest are applied for the R&D and
production of offshore and inland vessels. In 2011, CSSC Guangzhou
Marine Diesel Co., Ltd. separately signed marine diesel engine
technology import agreements with MAN and Wartsila. Taken together, MAN
had 16 China-based technology authorized dealers, while Wartsila had 9
ones.Published: April 2012
No. of Pages: 69
: Single User
License: US $ 1700 Corporate User License: US
$ 2700
Chinese marine diesel engine enterprises made remarkable progress in many aspects such as capacity, product structure and independent R&D through import.
Improvement in the Level of Production
In 2010, the low-speed marine diesel engine capacity of China hit 12 million horsepower, while the output realized 4.306 million horsepower, rising 39.4% over 2007.And the middle-speed marine diesel engine output registered 8.245 million horsepower, an increase of 73.1% over 2007.
In 2011, the production of marine diesel engine in China witnessed remarkable progress over 2010, with the output of Dalian Marine Diesel Co., Ltd., Yichang Marine Diesel Engine Co., Ltd., Zhenjiang CME Co., Ltd. reaching 101 units (1.63 million horsepower), 101 units (1.04 horsepower) and 713 units (including 14 units of low-speed engines). By contrast, both the output of Hefei RongAn Power Machinery Co., Ltd. and Jiangsu Antai Power Machinery Co., Ltd. doubled year-on-year to 40 units.
Gradual Perfection in Product Structure
In recent years, China’s marine diesel engine enterprises have intensified their efforts to adjust product structure, developed and realized mass-production of high-power, big-cylinder diameter or intelligent low-speed marine diesel engines, new-type middle-speed diesel engines, etc, making it possible for China to make gradual progress in the domestication R&D of patent marine diesel engines.
The IMO TierⅡ standard of marine diesel engine was formally effective since Jan.1, 2011. Coupled with the IMO TierⅢ standard that is to take effect in 2016, the relevant enterprises are forced to make continual effort to facilitate the structural adjustment of marine diesel engines, in a bid to accelerate the environment friendly-driven model.
Breakthrough in Independent R&D Capability
In April 2011, the first independently developed low-speed engine, 6S42MC/ZJ3#, by Zhenjiang CME Co. Ltd (ZJCME) was delivered; then in November, CSIC successfully developed middle-speed diesel engine, 6CS21/32, and formally launched it into the market
Global and China Epoxy Resin Industry Chain Report, 2011-2012 | Manufacturing and Construction
ReportsnReports add new market research"Global and China Epoxy Resin Industry Chain Report, 2011-2012" to its store. Epoxy resin is a polymeric compound
containing two or more epoxy groups and mainly finds application in
coatings, electrical systems and electronics, and composite materials
which together consume around 80% of the global epoxy resin.
In 2011, the global epoxy resin output approximated 2.24 million tons (80%-95% of which were Bisphenol A Epoxy Resin) and was mainly distributed in Asia, Western Europe and the United States where their output totally made up over 90% of the global total. Among these origins, China is the world’s largest producer and delivers about 37.1% of the global total output. As the European and American markets grow saturated, the increase of epoxy resin production is principally contributed by Asian countries especially China. In 2005-2011, the CAGR of epoxy resin output in China hit 10.8%, while that in Euro-American regions was only 3% or so.
Chinese epoxy resin manufacturers started late and few of them possess absolute scale advantages, featuring lower industry concentration degree than Euro-American nations. In 2011, the top 10 epoxy resin producers in Mainland China accounted for 60% of the national total capacity, while the capacity of the world’s top 6 epoxy resin manufacturers made up 61.8% of the global total. In this year, the top 3 epoxy resin manufacturers by capacity in Mainland China included Nan Ya Epoxy Resin (Kunshan) Co., Ltd., Sanmu Group and Kingboard Chemical Holdings Ltd.
China Epoxy Resin Industry
Nan Ya Epoxy
Resin (Kunshan) Co., Ltd. is the epoxy resin production base of
Taiwan-based Nan Ya Plastics Corporation. As the Phase-II boasting
annual capacity of 186.3 kt epoxy resins was put into production, the
company’s epoxy resin capacity amounted to 316 kt/a in 2011, occupying
17.6% of the total capacity in Chinese Mainland, and Nan Ya Plastic
Corporation thus becomes the world’s largest producer of epoxy resin and
enjoys capacity of 480 kt/a. Sanmu Group ranked No. 5 in the world in
2011 by virtue of 200 kt/a epoxy resin and now has a 70 kt/a epoxy resin
project under construction which will be put into operation in 2012.
Most epoxy resins are produced from a reaction between epichlorohydrin and bisphenol-A which boasted output of 450,000 tons and 400,000 tons respectively in Mainland China in 2011, with self-sufficiency rates of 99.1% and 41.0% separately.
The epichlorohydrin market in Chinese Mainland is dominated by domestic manufacturers. In 2011, the top 3 companies by capacity were Shandong Haili Chemical Industry Co., Ltd., Shandong Wudi Xinyue Chemical Co., Ltd. and Tianjin Botian Chemical Co., Ltd., of which Shandong Haili Chemical Industry maintained No. 1 in Asia and No. 2 in the world for its epichlorohydrin capacity.
The market demand for bisphenol A is largely dependent on imports. In 2011, the top 3 bisphenol A manufacturers by capacity in Mainland China included Bayer (Shanghai) Polymer Co., Ltd., Sinopec Mitsubishi Chemical Polycarbonate (Beijing) Co., Ltd. and Shanghai Sinopec Mitsui Chemicals Co., Ltd.
It is in the report that covers the followings:
In 2011, the global epoxy resin output approximated 2.24 million tons (80%-95% of which were Bisphenol A Epoxy Resin) and was mainly distributed in Asia, Western Europe and the United States where their output totally made up over 90% of the global total. Among these origins, China is the world’s largest producer and delivers about 37.1% of the global total output. As the European and American markets grow saturated, the increase of epoxy resin production is principally contributed by Asian countries especially China. In 2005-2011, the CAGR of epoxy resin output in China hit 10.8%, while that in Euro-American regions was only 3% or so.
Chinese epoxy resin manufacturers started late and few of them possess absolute scale advantages, featuring lower industry concentration degree than Euro-American nations. In 2011, the top 10 epoxy resin producers in Mainland China accounted for 60% of the national total capacity, while the capacity of the world’s top 6 epoxy resin manufacturers made up 61.8% of the global total. In this year, the top 3 epoxy resin manufacturers by capacity in Mainland China included Nan Ya Epoxy Resin (Kunshan) Co., Ltd., Sanmu Group and Kingboard Chemical Holdings Ltd.
China Epoxy Resin Industry
Published: April
2012
No. of Pages: 87
No. of Pages: 87
: Single User
License- US $ 2100 Corporate User License- US
$ 3300
Most epoxy resins are produced from a reaction between epichlorohydrin and bisphenol-A which boasted output of 450,000 tons and 400,000 tons respectively in Mainland China in 2011, with self-sufficiency rates of 99.1% and 41.0% separately.
The epichlorohydrin market in Chinese Mainland is dominated by domestic manufacturers. In 2011, the top 3 companies by capacity were Shandong Haili Chemical Industry Co., Ltd., Shandong Wudi Xinyue Chemical Co., Ltd. and Tianjin Botian Chemical Co., Ltd., of which Shandong Haili Chemical Industry maintained No. 1 in Asia and No. 2 in the world for its epichlorohydrin capacity.
The market demand for bisphenol A is largely dependent on imports. In 2011, the top 3 bisphenol A manufacturers by capacity in Mainland China included Bayer (Shanghai) Polymer Co., Ltd., Sinopec Mitsubishi Chemical Polycarbonate (Beijing) Co., Ltd. and Shanghai Sinopec Mitsui Chemicals Co., Ltd.
It is in the report that covers the followings:
- 20120114.gif The market size, competition pattern, consumption structure and regional distribution of the global epoxy resin industry;
- 20120114.gif The supply & demand, competitive landscape, import & export, price trend and projects to be built/under construction of Chinese epoxy resin industry;
- 20120114.gif The supply & demand, competition pattern, import & export, price trend and projects to be built/under construction of the upstream epichlorohydrin market;
- 20120114.gif The supply & demand, competition structure, import & export, price trend and projects to be built/under construction of the upstream bisphenol A market;
- 20120114.gif The demand structure and development forecast of epoxy resin in the downstream coatings, electrical systems and electronics, and composite materials;
- 20120114.gif The operation, production and marketing, suppliers, customers and capacity of 15 epoxy resin manufacturers at home and abroad
Subscribe to:
Comments (Atom)